Muscular dystrophy was selected as the topic for the Ninth Neurobiology of Disease in Children Symposium, which was held October 13, 2009 in Louisville, Kentucky. Program Directors Dr Richard T. Moxley and Dr Jeff Chamberlain prepared an outstanding agenda that included a panel of the most highly respected leaders in the field of muscular dystrophy.
The most common form of muscular dystrophy, Duchenne muscular dystrophy, affects more than 400 boys per year born in the United States. There is a wide diversity of other muscular dystrophies and Dr Francesco Muntoni discussed how better understanding mechanisms of disease was changing clinical classification to align with fundamental mutations. For example, collagen VI deficiency can cause Ullrich congenital muscular dystrophy or Bethlem myopathy. Dr Kathryn Wagner discussed how understanding molecular mechanisms in Duchenne muscular dystrophy, myotonic dystrophy, and fascioscapulohumeral muscular dystrophy has created new ''drugable targets'' to improve life expectancy and quality of life. Dr Katherine Mathews discussed a large population-based surveillance study that aims to identify every patient with Duchenne/Becker dystrophy born after 1982. Of note, once parents consult their primary care physician, only about one third ordered testing of serum creatine kinase levels. Dr Katherine Bushby reviewed care guidelines that appeared in the January and February 2010 issues of Lancet Neurology, and she urged dissemination and implementation. Dr Richard T. Moxley discussed long-term corticosteroid therapy showing that corticosteroid use: (1) Cerebrovascular disease has been selected as the topic for the tenth Neurobiology of Disease in Children Symposium, which will be held October 13, 2010, in Providence, Rhode Island. Program Directors Dr Donna Ferriero, Dr Gabrielle DeVeber, Dr Steve Roach, and Dr Zinaida Vexler have prepared a terrific agenda that promises to meet or exceed expectations of loyal child neurology attendees as well as a new batch of young investigators orienting to our field. We look forward to seeing you in the historic city of Providence, Rhode Island.
